Pontifax

Herzliya, Israel · VC · DeepTech Specialist

About

Pontifax Pontifax is one of Israel's leading life sciences venture firms, managing $800M+ across 6 funds since 2004. The team includes MDs, PhDs, and former pharmaceutical executives, providing the clinical and scientific depth needed to evaluate early-stage therapeutic programs. Notable exits include Kymera Therapeutics (IPO), BiomX (IPO), and Augmedics, with 30+ portfolio exits including 10+ IPOs and major M&A transactions. The investment focus covers therapeutics, drug discovery, medical devi

Industries

Stage focus

Geography

Notable investments

Kymera Therapeutics
BiomX
Augmedics

Request removal →

Raising from Pontifax?

I've worked with founders across the industrial stack. If Pontifax is on your list, I can help you map the introduction path, sharpen the narrative, and run a tight process.

Talk to Dan